[go: up one dir, main page]

ES2053571T3 - Uso de propionato de fluticasona en la preparacion de una composicion farmaceutica para el tratamiento de enfermedades intestinales. - Google Patents

Uso de propionato de fluticasona en la preparacion de una composicion farmaceutica para el tratamiento de enfermedades intestinales.

Info

Publication number
ES2053571T3
ES2053571T3 ES87311250T ES87311250T ES2053571T3 ES 2053571 T3 ES2053571 T3 ES 2053571T3 ES 87311250 T ES87311250 T ES 87311250T ES 87311250 T ES87311250 T ES 87311250T ES 2053571 T3 ES2053571 T3 ES 2053571T3
Authority
ES
Spain
Prior art keywords
treatment
preparation
fluticasone propionate
pharmaceutical composition
intestinal diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87311250T
Other languages
English (en)
Inventor
David Anthony Richards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ES2053571T3 publication Critical patent/ES2053571T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE AL EMPLEO DE PROPIONATO DE FLUTICASONA EN EL TRATAMIENTO DE ENFERMEDADES DEL SISTEMA DIGESTIVO CUANDO SE ADMINISTRA POR VIA ORAL, ESTOMACAL O RECTAL.
ES87311250T 1986-12-24 1987-12-21 Uso de propionato de fluticasona en la preparacion de una composicion farmaceutica para el tratamiento de enfermedades intestinales. Expired - Lifetime ES2053571T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868630913A GB8630913D0 (en) 1986-12-24 1986-12-24 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2053571T3 true ES2053571T3 (es) 1994-08-01

Family

ID=10609600

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87311250T Expired - Lifetime ES2053571T3 (es) 1986-12-24 1987-12-21 Uso de propionato de fluticasona en la preparacion de una composicion farmaceutica para el tratamiento de enfermedades intestinales.

Country Status (13)

Country Link
US (1) US4985418A (es)
EP (1) EP0278174B1 (es)
JP (1) JPS63233998A (es)
KR (1) KR880007084A (es)
AT (1) ATE86491T1 (es)
AU (1) AU8296987A (es)
CA (1) CA1302262C (es)
DE (1) DE3784693T2 (es)
DK (1) DK678887A (es)
ES (1) ES2053571T3 (es)
GB (2) GB8630913D0 (es)
NZ (1) NZ223045A (es)
ZA (1) ZA879464B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208226A (en) * 1989-09-08 1993-05-04 Glaxo Group Limited Medicaments
US5270305A (en) * 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
SE8903914D0 (sv) * 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
IT1256061B (it) * 1992-11-20 1995-11-23 Composizione terapeutica per uso rettale a base di flunisolide e/o deirelativi esteri per il trattamento di disordini intestinali a carattere infiammatorio
US6166024A (en) * 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
NL1006774C2 (nl) * 1996-08-14 1998-09-28 Univ Potchefstroom Anti-atherosclerose- en anti-trombotisch middel en het gebruik daarvan.
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US5993782A (en) * 1998-04-28 1999-11-30 Gardner; Conrad O. Therapeutic method for reversing hyposmia in a human patient
AU3596199A (en) * 1998-05-06 1999-11-23 Kobenhavns Universitet Treatment of celiac disease
GB9823036D0 (en) * 1998-10-22 1998-12-16 Glaxo Group Ltd Fluticasone lotion having improved vasoconstrictor activity
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050009848A1 (en) * 2003-07-10 2005-01-13 Icn Pharmaceuticals Switzerland Ltd. Use of antivirals against inflammatory bowel diseases
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) * 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
KR101245604B1 (ko) 2007-11-13 2013-03-21 메리테이지 파마, 인크. 코르티코스테로이드 조성물
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090143343A1 (en) * 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
CA2739465C (en) 2008-10-03 2017-01-31 Dr. Falk Pharma Gmbh Compositions and methods for the treatment of bowel diseases with granulated mesalamine
WO2010144865A2 (en) * 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
PT3403654T (pt) * 2009-10-01 2019-09-05 Adare Dev I L P Composições de corticosteroide administradas oralmente
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1291A (en) * 1980-02-15 1985-10-18 Glaxo Group Ltd Androstane 17 beta carbothioates
CA1201114A (en) * 1980-02-15 1986-02-25 Gordon H. Phillipps Androstane carbothioates
US4578221A (en) * 1980-04-23 1986-03-25 Glaxo Group Limited Androstane carbothioic acids
US4710495A (en) * 1980-07-10 1987-12-01 Otsuka Pharmaceutical Co., Ltd. Soft steroids having anti-inflammatory activity

Also Published As

Publication number Publication date
EP0278174A3 (en) 1990-06-27
DK678887D0 (da) 1987-12-22
GB2199747B (en) 1990-10-24
GB8729756D0 (en) 1988-02-03
DE3784693D1 (de) 1993-04-15
JPS63233998A (ja) 1988-09-29
DK678887A (da) 1988-06-25
NZ223045A (en) 1989-11-28
ATE86491T1 (de) 1993-03-15
GB2199747A (en) 1988-07-20
KR880007084A (ko) 1988-08-26
CA1302262C (en) 1992-06-02
EP0278174A2 (en) 1988-08-17
AU8296987A (en) 1988-06-30
DE3784693T2 (de) 1993-06-17
US4985418A (en) 1991-01-15
EP0278174B1 (en) 1993-03-10
GB8630913D0 (en) 1987-02-04
ZA879464B (en) 1988-12-28

Similar Documents

Publication Publication Date Title
ES2053571T3 (es) Uso de propionato de fluticasona en la preparacion de una composicion farmaceutica para el tratamiento de enfermedades intestinales.
LV5760A4 (lv) Jauns farmaceitisks preparats peroralai lietosanai
KR900701258A (ko) 결장 선택적 방출성을 갖는 경구용 약제학적 제제
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
FI862479L (fi) Oral farmaceutisk komposition.
NL194728B (nl) Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan.
BR1100860A (pt) Composto, droga antiinflamatória, composição farmacêutica, epìmero r e epìmero s do composto
MX9203417A (es) Compuestos de diarilo antiateroescleroticos.
IT8322855A0 (it) Composizione farmaceutica per la cura delle arteriopatie periferiche.
FI953358A0 (fi) Uudet paksusuolelle- ja sykkyräsuolelle spesifiset steroidijohdannaiset
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
IT8219482A0 (it) Composizione farmaceutica per la cura di affezioni della cavita'orale.
NO892764L (no) Medikamentell administreringsform for droevtyggere.
ATE74605T1 (de) Tetracyclische chinazolinderivate, herstellung und verwendung.
IT1241079B (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
DK559288A (da) Farmaceutisk praeparat for piperidinoalkanolderivater
ZA891234B (en) 6-oxo-pyridazine derivatives,a process for their preparation and medicaments containing these compounds
SE9003902D0 (sv) Solid dosage forms of a drug
ATE165239T1 (de) Orale arzeimittelzubereitung enthaltend diclofenac-natrium und eine organische säure
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
IT8519776A0 (it) Preparato per la cura esterna delle emorroidi.
NO882983D0 (no) Oral doseringsform for interferon for menneskelig bruk.
ATE44143T1 (de) 3-aminopropoxyphenyl-derivate, ihre herstellung und diese enthaltende pharmazeutische mittel.
BR7904659A (pt) Cadeira medica para pacientes,especialmente odontologica
ATE77820T1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 278174

Country of ref document: ES